MD Biosciences is a pre-clinical and clinical contract research organization (CRO) providing in vitro and in vivo nonclinical efficacy studies as well as a clinical biomarker and general chemistry analysis. Our focus is on inflammation, neurological and cardiovascular conditions. Our approach is to understand the need in the clinic and work backwards. In this way, we look to develop new methods for preclinical testing as well as new biomarkers that can be used in the clinical setting to improve upon current methods.
Contact us to discuss how MD Biosciences Preclinical Discovery services can partner with you to facilitate success in your preclinical development program.